AI-POWERED DIGITAL HEALTH INTERVENTIONS FOR PERSONALIZED TOBACCO CESSATION IN THE U.S.: IMPLEMENTING MACHINE LEARNING TECHNOLOGIES TO OPTIMIZE EVIDENCE-BASED CESSATION STRATEGIES USING REAL-TIME BEHAVIORAL AND PHYSIOLOGICAL DATA

Tobacco use remains one of the leading preventable causes of death, with traditional smoking-cessation treatments having low success rates for sustained abstinence (<10%), which highlights the need for innovative strategies. This paper examines opportunities to combine AI and machine learning technologies with interventions designed to help people quit smoking, particularly the potential for real-time data from wearables, covering behavior, physiology and other personal factors, to improve evidence-based cessation approaches within US healthcare systems. The study used systematic review methods that include RCTs, real-world evidence from health systems, regulatory issues and demographics. The paper summarizes current evidence on AI-powered digital health interventions for smoking cessation. The findings indicated that though conversational AI chatbots and machine learning recommender systems show early signs of effectiveness, significant implementation challenges remain, such as HIPAA regulation complexities, disparities caused by fragmented mHealth data standards, limited evidence on cost-effectiveness and wide variation in wearable device adoption across different age, income, education and racial/ethnic groups. Major US surveillance systems like BRFSS and PATH, along with integrated healthcare organizations such as Veterans Affairs and Kaiser Permanente, demonstrate that systematic methods substantially increase evidence-based treatment delivery, but AI applications in this area are still in early development. The review concludes that realizing AI's full potential in tobacco cessation requires addressing technical, clinical, regulatory and equity challenges through implementation science approaches focused on real-world effectiveness, sustainability and equitable access for all populations affected by tobacco use. Keywords: AI, Digital Health, Tobacco Cessation, Personalization, Machine Learning, Behavior

Authors

Publication Details

Journal
EPRA International Journal of Multidisciplinary Research (IJMR)
Published
2025-10-14
DOI
https://doi.org/10.36713/epra24330
Primary Topic
Cardiovascular Health and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI-POWERED DIGITAL HEALTH INTERVENTIONS FOR PERSONALIZED TOBACCO CESSATION IN THE U.S.: IMPLEMENTING MACHINE LEARNING TECHNOLOGIES TO OPTIMIZE EVIDENCE-BASED CESSATION STRATEGIES USING REAL-TIME BEHAVIORAL AND PHYSIOLOGICAL DATA

Henry Asusheyi Obajaja, Glory Edinam Afeti
EPRA International Journal of Multidisciplinary Research (IJMR)
Cardiovascular Health and Risk Factors
article

AI-POWERED DIGITAL HEALTH INTERVENTIONS FOR PERSONALIZED TOBACCO CESSATION IN THE U.S.: IMPLEMENTING MACHINE LEARNING TECHNOLOGIES TO OPTIMIZE EVIDENCE-BASED CESSATION STRATEGIES USING REAL-TIME BEHAVIORAL AND PHYSIOLOGICAL DATA

Henry Asusheyi Obajaja, Glory Edinam Afeti
article en

Abstract

Tobacco use remains one of the leading preventable causes of death, with traditional smoking-cessation treatments having low success rates for sustained abstinence (<10%), which highlights the need for innovative strategies. This paper examines opportunities to combine AI and machine learning technologies with interventions designed to help people quit smoking, particularly the potential for real-time data from wearables, covering behavior, physiology and other personal factors, to improve evidence-based cessation approaches within US healthcare systems. The study used systematic review methods that include RCTs, real-world evidence from health systems, regulatory issues and demographics. The paper summarizes current evidence on AI-powered digital health interventions for smoking cessation. The findings indicated that though conversational AI chatbots and machine learning recommender systems show early signs of effectiveness, significant implementation challenges remain, such as HIPAA regulation complexities, disparities caused by fragmented mHealth data standards, limited evidence on cost-effectiveness and wide variation in wearable device adoption across different age, income, education and racial/ethnic groups. Major US surveillance systems like BRFSS and PATH, along with integrated healthcare organizations such as Veterans Affairs and Kaiser Permanente, demonstrate that systematic methods substantially increase evidence-based treatment delivery, but AI applications in this area are still in early development. The review concludes that realizing AI's full potential in tobacco cessation requires addressing technical, clinical, regulatory and equity challenges through implementation science approaches focused on real-world effectiveness, sustainability and equitable access for all populations affected by tobacco use. Keywords: AI, Digital Health, Tobacco Cessation, Personalization, Machine Learning, Behavior

EPRA International Journal of Multidisciplinary Research (IJMR)
Openalex Percentile: Top 56%
Cardiovascular Health and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.